Inicio › Leucemia mielógena aguda › Illinois › Springfield
Ensayos clínicos de Leucemia mielógena aguda en Springfield, IL
8 estudios para Leucemia mielógena aguda buscan participantes en centros de Springfield y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ReclutandoFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ReclutandoFase 3
- Southern Illinois University School of Medicine, Springfield
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutandoFase 1/2
- Southern Illinois University School of Medicine, Springfield
Más información sobre Leucemia mielógena aguda en MedlinePlus
Ensayos de Leucemia mielógena aguda en otras ciudades
- Houston, TX88 estudios
- New York City, NY51 estudios
- Boston, MA44 estudios
- Baldwin Park, CA41 estudios
- Seattle, WA40 estudios
- Durham, NC34 estudios
- Columbus, OH34 estudios
- Philadelphia, PA33 estudios
- Atlanta, GA30 estudios
- Tampa, FL30 estudios
- Chicago, IL27 estudios
- Los Angeles, CA25 estudios
Otros estudios en Springfield
- Cáncer de pulmón de células no pequeñas14 estudios
- Cáncer de pulmón13 estudios
- Cáncer del colon y del recto9 estudios
- Cáncer de seno8 estudios
- Cáncer de riñón (carcinoma de células renales)6 estudios
- Cáncer de vejiga6 estudios
- Cáncer de próstata6 estudios
- Carcinoma de células escamosas de cabeza y cuello6 estudios
- Cáncer (todos los tipos)5 estudios
- Cáncer de páncreas5 estudios
- Melanoma5 estudios
- Cáncer metastásico4 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.